Andrew Jacob Silver
Chief Financial Officer · CRISPR Therapeutics AG
Individual
- 2026
- Oct 28, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Jacob Silver files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samarth Kulkarni - $9.60M in CRSP purchases and sales in the last 12 months
- Raju Prasad - $5.10M in CRSP purchases and sales in the last 12 months
- James R. Kasinger - $1.37M in CRSP purchases and sales in the last 12 months
- Simeon George - $720K in CRSP purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Jacob Silver?
Andrew Jacob Silver is a corporate insider, tracked as Chief Financial Officer of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Jacob Silver submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.